Respigam is a medication that is used to prevent respiratory syncytial virus (RSV) in high-risk infants and young children. RSV is a common virus that can cause serious respiratory infections in young children, especially those with weakened immune systems or underlying health conditions.

Respigam works by providing passive immunity to RSV, meaning it contains antibodies that can help protect against the virus. It is typically given as an injection and is most effective when administered before the start of RSV season.

It is important to follow the dosing schedule recommended by your healthcare provider to ensure maximum protection against RSV. Common side effects of Respigam may include mild fever, irritability, or injection site reactions. If you or your child experience any severe or persistent side effects, it is important to contact your healthcare provider immediately.

It is important to note that Respigam is not a treatment for RSV once an infection has already occurred. It is intended for prevention purposes only. If you suspect that you or your child may have RSV, it is important to seek medical attention promptly for proper diagnosis and treatment.

Overall, Respigam can be a valuable tool in protecting high-risk infants and young children from the serious complications of RSV. If you have any questions or concerns about Respigam or its use, do not hesitate to speak with your healthcare provider for more information.